Cargando…
Persistence of antibody responses to COVID-19 vaccines among participants in the COVID-19 Community Research Partnership
INTRODUCTION: High levels of immunity to SARS-CoV-2 in the community correlate with protection from COVID-19 illness. Measuring COVID-19 antibody seroprevalence and persistence may elucidate the level and length of protection afforded by vaccination and infection within a population. METHODS: We mea...
Autores principales: | Berry, Andrea A., Tjaden, Ashley H., Renteria, Jone, Friedman-Klabanoff, DeAnna, Hinkelman, Amy N., Gibbs, Michael A., Ahmed, Amina, Runyon, Michael S., Schieffelin, John, Santos, Robert P., Oberhelman, Richard, Bott, Matthew, Correa, Adolfo, Edelstein, Sharon L., Uschner, Diane, Wierzba, Thomas F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10462856/ https://www.ncbi.nlm.nih.gov/pubmed/37649617 http://dx.doi.org/10.1016/j.jvacx.2023.100371 |
Ejemplares similares
-
Self-Reported SARS-CoV-2 Vaccination Is Consistent with Electronic Health Record Data among the COVID-19 Community Research Partnership
por: Tjaden, Ashley H., et al.
Publicado: (2022) -
Vaccine-induced seroconversion in participants in the North Carolina COVID-19 community Research Partnership
por: Friedman-Klabanoff, DeAnna J., et al.
Publicado: (2022) -
COVID-19 Symptoms by Variant Period in the North Carolina COVID-19 Community Research Partnership, North Carolina, USA
por: DeWitt, Michael E., et al.
Publicado: (2023) -
588. Seroconversion Among Adults After Receiving At Least One Dose of a COVID-19 Vaccine: COVID-19 Community Research Partnership, Mid-Atlantic, Southeast and Southern United States, December 2020-May 2021
por: Friedman-Klabanoff, DeAnna J, et al.
Publicado: (2021) -
Estimated COVID-19 vaccine effectiveness against seroconversion from SARS-CoV-2 Infection, March–October, 2021
por: Plumb, Ian D., et al.
Publicado: (2023)